ES2147184T3 - Composiciones de canales calcicos humanos y procedimientos. - Google Patents

Composiciones de canales calcicos humanos y procedimientos.

Info

Publication number
ES2147184T3
ES2147184T3 ES92918611T ES92918611T ES2147184T3 ES 2147184 T3 ES2147184 T3 ES 2147184T3 ES 92918611 T ES92918611 T ES 92918611T ES 92918611 T ES92918611 T ES 92918611T ES 2147184 T3 ES2147184 T3 ES 2147184T3
Authority
ES
Spain
Prior art keywords
human calcium
calcium channels
procedures
compositions
subunit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92918611T
Other languages
English (en)
Inventor
Michael Miller Harpold
Steven Bradley Ellis
Mark Edward Williams
Daniel Howard Feldman
Ann Francis Mccue
Robert Brenner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/745,206 external-priority patent/US5429921A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2147184T3 publication Critical patent/ES2147184T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)

Abstract

SE DESCRIBE UN ADN AISLADO QUE CODIFICA CADA UNO DE LOS CANALES DE CALCIO HUMANOS (ALFA)1-,(ALFA)2-, Y SUBUNIDADES UE INCLUYE SUBUNIDADES QUE SURGEN COMO VARIANTES DE EMPALME DE TRANSCRIPCIONES PRIMARIAS. LAS CELULAS Y VECTORES QUE CONTIENEN EL ADN Y LOS METODOS PARA IDENTIFICAR LOS COMPUESTOS QUE MODULAN LA ACTIVIDAD DE LOS CANALES DE CALCIO HUMANOS.
ES92918611T 1991-08-15 1992-08-14 Composiciones de canales calcicos humanos y procedimientos. Expired - Lifetime ES2147184T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/745,206 US5429921A (en) 1988-04-04 1991-08-15 Assays for agonists and antagonists of recombinant human calcium channels
US86835492A 1992-04-10 1992-04-10

Publications (1)

Publication Number Publication Date
ES2147184T3 true ES2147184T3 (es) 2000-09-01

Family

ID=27114421

Family Applications (2)

Application Number Title Priority Date Filing Date
ES92918611T Expired - Lifetime ES2147184T3 (es) 1991-08-15 1992-08-14 Composiciones de canales calcicos humanos y procedimientos.
ES99119092T Expired - Lifetime ES2235417T3 (es) 1991-08-15 1992-08-14 Composiciones de canales de calcio humanos y procedimientos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99119092T Expired - Lifetime ES2235417T3 (es) 1991-08-15 1992-08-14 Composiciones de canales de calcio humanos y procedimientos.

Country Status (10)

Country Link
EP (3) EP1469074B1 (es)
JP (1) JPH06509717A (es)
AT (2) ATE286976T1 (es)
AU (1) AU677571B2 (es)
CA (1) CA2113203C (es)
DE (2) DE69233469T2 (es)
DK (1) DK0598840T3 (es)
ES (2) ES2147184T3 (es)
GR (1) GR3033961T3 (es)
WO (1) WO1993004083A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387696B1 (en) * 1988-04-04 2002-05-14 Merck & Co., Inc. Human calcium channel compositions and methods
US5876958A (en) * 1988-04-04 1999-03-02 Sibia Neurosciences, Inc. Assays of cells expressing human calcium channels containing α1 β subunits
US5874236A (en) * 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
US5912122A (en) 1993-06-04 1999-06-15 Sibia Neurosciences, Inc. Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6
US5623051A (en) * 1994-11-10 1997-04-22 University Of Washington Methods and compositions for screening for presynaptic calcium channel blockers
US5712158A (en) * 1995-06-06 1998-01-27 Warner-Lambert Company Cell line for the rapid expression of functional calcium channels
US6040436A (en) * 1996-09-16 2000-03-21 American Home Products Corporation Nucleic acid encoding human neuronal calcium channel subunits
DE69836229T2 (de) * 1997-12-03 2007-08-23 Merck & Co., Inc. Zusammensetzungen von durch niedervolt aktivierten kalziumkanälen und verfahren
WO1999029847A1 (en) * 1997-12-05 1999-06-17 Loyola University Of Chicago T-type voltage-gated calcium channels and method of using same
ES2378977T3 (es) 1998-03-13 2012-04-19 Brown University Research Foundation Isoforma del canal de calcio del tipo N humano y usos de la misma
CA2299611A1 (en) 1998-06-02 1999-12-09 Torben Bech-Hansen Retinal calcium channel (alpha)1f-subunit gene
AU780591B2 (en) * 1999-05-05 2005-04-07 Lexicon Genetics Incorporated Novel human ion channel proteins
CA2384911C (en) 1999-09-16 2008-07-22 Warner-Lambert Company Method for the screening of .alpha.2. delta.-1 subunit binding ligands
US6783952B1 (en) 1999-09-16 2004-08-31 Warner-Lambert Company Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same
US6962973B1 (en) 1999-09-16 2005-11-08 Warner-Lambert Company Porcine α2δ-1 calcium channel subunit cDNA and soluble secreted α2δ-1 subunit polypeptides
ATE405156T1 (de) * 1999-10-26 2008-09-15 Eisai R&D Man Co Ltd N-KALZIUM-KANAL-ßKNOCKOUT-TIERß
US7067714B1 (en) 1999-10-26 2006-06-27 Eisai Research Institute N-calcium channel knockout animal
US7294691B1 (en) 2000-09-18 2007-11-13 Warner Lambert Company Soluble secreted α2δ-2calcium channel subunit polypeptide
US20050208044A1 (en) 2002-03-19 2005-09-22 Jane Barclay Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
DE68926713T2 (de) * 1988-04-04 1996-11-14 Salk Inst Biotech Ind Calciumkanal-zusammensetzungen und verfahren
US5386025A (en) * 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
DE4110785A1 (de) * 1991-04-04 1992-10-08 Bayer Ag Gewebe-spezifische humane neuronale calcium-kanal-subtypen und deren verwendung

Also Published As

Publication number Publication date
EP1469074B1 (en) 2008-11-26
DE69230938T2 (de) 2000-10-12
CA2113203A1 (en) 1993-03-04
WO1993004083A1 (en) 1993-03-04
GR3033961T3 (en) 2000-11-30
EP0598840B1 (en) 2000-04-19
DE69230938D1 (de) 2000-05-25
EP1469074A1 (en) 2004-10-20
ATE191920T1 (de) 2000-05-15
DK0598840T3 (da) 2000-10-02
ATE286976T1 (de) 2005-01-15
AU677571B2 (en) 1997-05-01
EP0598840A1 (en) 1994-06-01
CA2113203C (en) 2001-01-02
EP0992585A2 (en) 2000-04-12
JPH06509717A (ja) 1994-11-02
ES2235417T3 (es) 2005-07-01
EP0992585A3 (en) 2000-11-15
AU2495792A (en) 1993-03-16
DE69233469T2 (de) 2005-12-22
EP0992585B1 (en) 2005-01-12
DE69233469D1 (de) 2005-02-17

Similar Documents

Publication Publication Date Title
ATE139542T1 (de) Calciumkanal-zusammensetzungen und verfahren
ES2147184T3 (es) Composiciones de canales calcicos humanos y procedimientos.
DE69432794D1 (de) Menschliche kalziumkanale und verwendungen davon
ATE342973T1 (de) Zusammensetzungen von durch niedervolt aktivierten kalziumkanälen und verfahren
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
DE3650387T2 (de) Verfahren zur Herstellung polysubstituierten Piperazinone.
NO944406D0 (no) Nye 7 se inhibitorer
ATE162079T1 (de) Verwendung von antikörper enthaltenden präparationen zur immunsuppression
DE69727312D1 (de) 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals
MX9401175A (es) Inhibidores de la acetilcolinesterasa sililada.
BR9708347A (pt) Compostos de tetrahidorbeta-carbonila
DE69510545T2 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
DK92388A (da) Diorganopolysiloxangruppeholdige disubstituerede n,n'-bis-maleimider samt fremgangsmaade til fremstilling deraf
TR199901386T2 (en) �midazopiridazinler.
ES2000320A6 (es) Procedimiento para la preparacion de compuestos de 1-oxa-3-oxo-4,8-diaza-espiro (4,5) decano
ATE49881T1 (de) Sebosuppressive kosmetische mittel, enthaltend alkoxyaryl-alkanole.
AU7999687A (en) Active compounds for preventing tumor metastases
NO170936C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte vinylcefalosporiner
DK0668872T3 (da) Calciumkanalblokerende polypeptider fra Theraphosidaeaphonopelma
UA10769C2 (uk) Лікарський засіб для профілактики передчасhого старіhhя та лікуваhhя вікових патологій
ES2038638T3 (es) Sustancias moduladoras del canal del calcio.
SU1746666A1 (ru) Замещенные 3-аминометиленпирролидин-2,4-дионы, обладающие противосудорожной активностью
SE8405285D0 (sv) Redskap for preparering av skidspar

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 598840

Country of ref document: ES